Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Capsid | 1 | 2006 | 197 | 0.29 | Why? |
Capsid Proteins | 1 | 2006 | 365 | 0.26 | Why? |
Virus Assembly | 1 | 2006 | 438 | 0.25 | Why? |
Rotavirus | 1 | 2006 | 329 | 0.25 | Why? |
Antibodies, Neutralizing | 11 | 2021 | 25288 | 0.23 | Why? |
Neutralization Tests | 4 | 2021 | 6698 | 0.21 | Why? |
Erythema Infectiosum | 1 | 2017 | 31 | 0.17 | Why? |
Th1 Cells | 2 | 2021 | 1228 | 0.17 | Why? |
Parvovirus B19, Human | 1 | 2017 | 73 | 0.17 | Why? |
Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.15 | Why? |
Antibodies, Viral | 11 | 2021 | 51949 | 0.14 | Why? |
Vaccines, Virus-Like Particle | 1 | 2017 | 312 | 0.13 | Why? |
Antigens, Viral | 2 | 2021 | 6298 | 0.11 | Why? |
Vaccines, Synthetic | 5 | 2021 | 3231 | 0.10 | Why? |
Anemia, Sickle Cell | 1 | 2017 | 546 | 0.10 | Why? |
Viral Vaccines | 2 | 2020 | 7560 | 0.09 | Why? |
Spike Glycoprotein, Coronavirus | 9 | 2021 | 37182 | 0.09 | Why? |
Injections, Intramuscular | 2 | 2021 | 800 | 0.09 | Why? |
Polysorbates | 2 | 2018 | 125 | 0.09 | Why? |
Microscopy, Immunoelectron | 1 | 2006 | 49 | 0.08 | Why? |
Squalene | 2 | 2018 | 196 | 0.08 | Why? |
T-Lymphocytes | 2 | 2021 | 6670 | 0.08 | Why? |
Single-Blind Method | 2 | 2020 | 1283 | 0.08 | Why? |
Carboxypeptidases | 1 | 2005 | 148 | 0.08 | Why? |
Multiprotein Complexes | 1 | 2006 | 182 | 0.07 | Why? |
Disease Models, Animal | 2 | 2021 | 10998 | 0.07 | Why? |
Cathepsins | 1 | 2005 | 204 | 0.07 | Why? |
Protein Structure, Quaternary | 1 | 2006 | 455 | 0.07 | Why? |
Microscopy, Electron, Transmission | 1 | 2006 | 605 | 0.07 | Why? |
Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.06 | Why? |
Mutation | 2 | 2021 | 12376 | 0.06 | Why? |
Influenza Vaccines | 1 | 2018 | 2941 | 0.06 | Why? |
Membrane Glycoproteins | 2 | 2006 | 2273 | 0.05 | Why? |
Cell Line | 3 | 2021 | 12040 | 0.05 | Why? |
Solubility | 1 | 2021 | 382 | 0.05 | Why? |
Vaccination | 3 | 2021 | 19050 | 0.05 | Why? |
Interleukin-2 | 1 | 2021 | 443 | 0.05 | Why? |
Recombinant Proteins | 2 | 2006 | 3786 | 0.05 | Why? |
Hemagglutination Inhibition Tests | 1 | 2018 | 191 | 0.05 | Why? |
Mice | 3 | 2021 | 21357 | 0.04 | Why? |
Adjuvants, Immunologic | 2 | 2018 | 1709 | 0.04 | Why? |
Virion | 1 | 2006 | 1444 | 0.04 | Why? |
Young Adult | 7 | 2021 | 93724 | 0.04 | Why? |
Viral Envelope Proteins | 2 | 2006 | 3539 | 0.04 | Why? |
Respirovirus Infections | 1 | 2017 | 90 | 0.04 | Why? |
Cysteine Endopeptidases | 1 | 2005 | 1557 | 0.04 | Why? |
Immunoglobulin G | 4 | 2021 | 21571 | 0.04 | Why? |
Animals | 6 | 2021 | 78931 | 0.04 | Why? |
Saccharomyces cerevisiae | 1 | 2017 | 339 | 0.04 | Why? |
Protein Multimerization | 1 | 2021 | 1336 | 0.04 | Why? |
Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
CD8-Positive T-Lymphocytes | 2 | 2021 | 5837 | 0.03 | Why? |
Pain | 1 | 2021 | 1084 | 0.03 | Why? |
Protein Binding | 2 | 2006 | 11430 | 0.03 | Why? |
Immunization, Secondary | 1 | 2020 | 1649 | 0.03 | Why? |
Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
Adult | 7 | 2021 | 244371 | 0.03 | Why? |
Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
Adolescent | 4 | 2021 | 86841 | 0.03 | Why? |
Mice, Inbred BALB C | 1 | 2021 | 5814 | 0.03 | Why? |
Headache | 1 | 2020 | 2257 | 0.03 | Why? |
Male | 8 | 2021 | 367725 | 0.02 | Why? |
Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.02 | Why? |
Fatigue | 1 | 2020 | 2479 | 0.02 | Why? |
Humans | 14 | 2021 | 930598 | 0.02 | Why? |
Female | 8 | 2021 | 380317 | 0.02 | Why? |
Swine | 1 | 2018 | 3352 | 0.02 | Why? |
Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
Vero Cells | 2 | 2021 | 14117 | 0.02 | Why? |
Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
Respiratory System | 1 | 2021 | 3213 | 0.02 | Why? |
Peptidyl-Dipeptidase A | 2 | 2006 | 9659 | 0.02 | Why? |
Internationality | 1 | 2021 | 3297 | 0.02 | Why? |
Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
Cross-Linking Reagents | 1 | 2006 | 91 | 0.02 | Why? |
Retroviridae | 1 | 2005 | 49 | 0.02 | Why? |
Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
SARS Virus | 2 | 2006 | 13021 | 0.02 | Why? |
Protein Folding | 1 | 2006 | 270 | 0.02 | Why? |
Germany | 1 | 2020 | 9196 | 0.02 | Why? |
Green Fluorescent Proteins | 1 | 2005 | 450 | 0.02 | Why? |
Aging | 1 | 2021 | 3581 | 0.02 | Why? |
Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
Microscopy, Electron | 1 | 2006 | 830 | 0.02 | Why? |
Hydrogen-Ion Concentration | 1 | 2006 | 993 | 0.01 | Why? |
Lysosomes | 1 | 2005 | 416 | 0.01 | Why? |
Endosomes | 1 | 2005 | 490 | 0.01 | Why? |
Cathepsin L | 1 | 2005 | 566 | 0.01 | Why? |
Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
Protein Structure, Tertiary | 1 | 2006 | 1565 | 0.01 | Why? |
Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
Species Specificity | 1 | 2005 | 1356 | 0.01 | Why? |
Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
Aged | 3 | 2021 | 215776 | 0.01 | Why? |
Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
Coronavirus | 1 | 2005 | 18339 | 0.01 | Why? |
China | 1 | 2021 | 50654 | 0.01 | Why? |
Influenza, Human | 1 | 2018 | 10779 | 0.01 | Why? |
RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
Child | 1 | 2021 | 70012 | 0.01 | Why? |
Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
Receptors, Virus | 1 | 2006 | 5659 | 0.01 | Why? |
Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
Dormitzer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(194)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_